V
Ventaira Pharmaceuticals
Specialty pharmaceutical company leveraging science and engineering for more effective medicines
About Ventaira Pharmaceuticals
Ventaira Pharmaceuticals, formerly known as BattellePharma, was a specialty pharmaceutical company established in 1997 and spun out from the Battelle Memorial Institute in 2000. The company focused on developing pharmaceutical products for inhalation to treat pulmonological diseases. The core of its operations was a proprietary drug delivery technology called Mystic™, an electrohydrodynamic (EHD) aerosolization process. This electronic nebulization technique applied an electrical field to a conductive liquid, creating a soft mist aerosol designed to deliver drugs more efficiently to and through the lungs.
The company's pipeline included inhaled drugs such as fentanyl for breakthrough pain and salmeterol for asthma. Ventaira's primary business strategy involved leveraging its Mystic™ technology to improve the delivery of new or existing drugs, aiming to create more effective treatments. One of its development programs involved a study with fluticasone propionate, a common asthma treatment, using the Ventaira Phoenix device, which demonstrated a high proportion of medicated aerosol delivery to the lungs for a hand-held device. The company's President and CEO was Leslie Williams.
Ventaira Pharmaceuticals was venture-capital-backed, raising a total of $39.5 million from investors including Battelle Ventures, Early Stage Partners, Fletcher Spaght Ventures, and Merlin BioMed Group. The company secured significant funding rounds, including $25 million in a Series B round in February 2003 and $13.5 million in a Series C round in October 2005. Despite its technological advancements and funding, Ventaira announced in October 2007 that its assets would be acquired by its parent organization, Battelle. Following the acquisition, Ventaira's clinical development programs and device development work were discontinued, and the company ceased operations by the end of 2007.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2000
- Headquarters
- Columbus, United States
- Employees
- 6
- Open positions
- None listed
- Dealroom signal
- 22.7/100
- Industry
- Health
- Sub-industry
- Pharmaceutical
- Sector
- Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
News
Open roles
Funding history
Company financing events and reported valuations.
Growth signals
Latest recorded traffic for Ventaira Pharmaceuticals is 240 monthly website visits. Ventaira Pharmaceuticals's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Ventaira Pharmaceuticals in the Columbus ecosystem
The Ventaira Pharmaceuticals office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A6 investors entered at this stage
Pfizer
TL Ventures- MBMerlin Biomed
Battelle Memorial Institute
Fletcher Spaght Ventures
Richardson Capital
Series B and later4 investors entered at this stage
- RPReservoir Venture Partners
Battelle Ventures
Safeguard Scientifics- NCNovitas Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Ventaira Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Ventaira Pharmaceuticals’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









